OBJECTIVE: Adjuvant radiation therapy (RT) is an essential part of combined limb-sparing treatment of soft-tissue sarcoma (STS). Elderly or medically unfit patients often have difficulty in completing 6-7 weeks of standard fractionated daily treatment. Our aim was to evaluate the efficacy of a hypofractionated adjuvant approach with RT for STS in elderly and debilitated patients. METHODS: 21 elderly patients were treated with a short course of adjuvant RT (39-48 Gy, 3 Gy per fraction) for STS. The medical records of the patients were retrospectively reviewed for local or distant recurrence and side effects of RT. RESULTS: At a mean 26 months of follow-up, three local recurrences (14%) were detected. Eight patients (38%) had lung metastases during the observed period. Three of them died from metastatic disease. The hypofractionated radiation was well tolerated with minimum long-term side effects. CONCLUSION: Hypofractionated adjuvant radiation appears to be an effective treatment in terms of local control in elderly and debilitated patients. ADVANCES IN KNOWLEDGE: The results of this study might provide an alternative to commonly used standard fractionation of radiotherapy in sarcoma patients.
OBJECTIVE: Adjuvant radiation therapy (RT) is an essential part of combined limb-sparing treatment of soft-tissue sarcoma (STS). Elderly or medically unfit patients often have difficulty in completing 6-7 weeks of standard fractionated daily treatment. Our aim was to evaluate the efficacy of a hypofractionated adjuvant approach with RT for STS in elderly and debilitated patients. METHODS: 21 elderly patients were treated with a short course of adjuvant RT (39-48 Gy, 3 Gy per fraction) for STS. The medical records of the patients were retrospectively reviewed for local or distant recurrence and side effects of RT. RESULTS: At a mean 26 months of follow-up, three local recurrences (14%) were detected. Eight patients (38%) had lung metastases during the observed period. Three of them died from metastatic disease. The hypofractionated radiation was well tolerated with minimum long-term side effects. CONCLUSION: Hypofractionated adjuvant radiation appears to be an effective treatment in terms of local control in elderly and debilitated patients. ADVANCES IN KNOWLEDGE: The results of this study might provide an alternative to commonly used standard fractionation of radiotherapy in sarcomapatients.
Authors: F C Eilber; G Rosen; J Eckardt; C Forscher; S D Nelson; M Selch; F Dorey; F R Eilber Journal: J Clin Oncol Date: 2001-07-01 Impact factor: 44.544
Authors: Christopher W Ryan; Anthony G Montag; Janet R Hosenpud; Brian Samuels; James B Hayden; Arthur Y Hung; Atiya Mansoor; Terrance D Peabody; Arno J Mundt; Samir Undevia Journal: Cancer Date: 2008-06 Impact factor: 6.860
Authors: Mark D McKee; Dong Feng Liu; John J Brooks; John F Gibbs; Deborah L Driscoll; William G Kraybill Journal: J Surg Oncol Date: 2004-02 Impact factor: 3.454
Authors: Meena Bedi; Reena Singh; John A Charlson; Tracy Kelly; Candice Johnstone; Adam Wooldridge; Donald A Hackbarth; Nicole Moore; John C Neilson; David M King Journal: Adv Radiat Oncol Date: 2022-01-25
Authors: Daniel Y Joh; Gary D Kao; Surya Murty; Melissa Stangl; Lova Sun; Ajlan Al Zaki; Xiangsheng Xu; Stephen M Hahn; Andrew Tsourkas; Jay F Dorsey Journal: Transl Oncol Date: 2013-12-01 Impact factor: 4.243
Authors: Gausihi Sivarajah; Emma Davies; Anna Hurley; Dirk C Strauss; Myles J F Smith; Andrew J Hayes Journal: Ann Surg Oncol Date: 2022-02-03 Impact factor: 4.339